
IRON
Disc Medicine Inc.
$59.65
-$0.01(-0.03%)
50
Overall
--
Value
75
Tech
26
Quality
Market Cap
$2.08B
Volume
214.79K
52W Range
$30.82 - $68.73
Target Price
$97.67
Order:
Income Statement
Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|
COST OF GOODS SOLD | |||||||
Cost of Revenue | -- | $-600.0K | -- | -- | -- | ||
GROSS PROFIT | |||||||
Gross Profit | -- | $600.0K | -- | -- | -- | ||
OPERATING EXPENSES | |||||||
Operating Expenses | $34.0M | $30.9M | $47.5M | $91.1M | $129.7M | ||
Research & Development | $28.2M | $25.2M | $33.4M | $69.3M | $96.7M | ||
Research Expense | $28.2M | $25.2M | $33.4M | $69.3M | $96.7M | ||
Selling, General & Administrative | $5.9M | $5.8M | $14.0M | $21.9M | $33.0M | ||
General & Administrative Expenses | $5.9M | $5.8M | $14.0M | $21.9M | $33.0M | ||
Salaries & Wages | $-983.0K | $-507.0K | $-2.1M | $-5.5M | $-16.8M | ||
Depreciation & Amortization | $300.0K | $-200.0K | -- | $100.0K | $200.0K | ||
Depreciation & Amortization | $300.0K | $-200.0K | -- | $100.0K | $200.0K | ||
Other Operating Expenses | -- | $-700.0K | $599.0K | $581.0K | $1.1M | ||
OPERATING INCOME | |||||||
Operating income | $-34.0M | $-30.9M | $-47.5M | $-91.1M | $-129.7M | ||
EBITDA | $-33.7M | $-30.9M | $-47.4M | $-76.2M | $-108.8M | ||
NON-OPERATING ITEMS | |||||||
Interest Expense (Non-Operating) | $6.8M | $2.2M | -- | -- | -- | ||
Intinc | $37.0K | $14.0K | $709.0K | $14.8M | $21.3M | ||
Net Non-Operating Interest Income/Expense | $-6.8M | $14.0K | $709.0K | $14.8M | $21.3M | ||
Gain on Sale of Securities | -- | $-5.0M | $-61.0K | -- | -- | ||
Other Income/Expense | $8.0K | $5.0M | $-61.0K | $2.0K | $2.0K | ||
Other Special Charges | $-8.0K | $-724.0K | -- | $-2.0K | $-2.0K | ||
SPECIAL ITEMS | |||||||
Restructring And Mn A Income | -- | $-1.4M | -- | -- | -- | ||
Special Income Charges | -- | $1.4M | -- | -- | -- | ||
PRE-TAX INCOME | |||||||
EBIT | $-34.0M | $-30.9M | $-47.5M | $-76.3M | $-109.0M | ||
Pre-Tax Income | $-40.8M | $-36.0M | $-46.8M | $-76.3M | $-109.0M | ||
INCOME TAX | |||||||
Tax Provision | -- | -- | -- | $99.0K | $355.0K | ||
NET INCOME | |||||||
Net Income | $-40.8M | $-36.0M | $-46.8M | $-76.4M | $-109.4M | ||
Net Income (Continuing Operations) | $-40.8M | $-36.0M | $-46.8M | $-76.4M | $-109.4M | ||
Net Income (Discontinued Operations) | $-40.8M | $-36.0M | $-46.8M | $-76.4M | $-109.4M | ||
Net Income (Common Stockholders) | $-40.8M | $-36.0M | $-46.8M | $-76.4M | $-109.4M | ||
Normalized Income | -- | -- | -- | -- | $-107.9M | ||
TOTALS | |||||||
Total Expenses | $34.0M | $30.9M | $47.5M | $91.1M | $129.7M | ||
SHARE & EPS DATA | |||||||
Average Shares Outstanding | $15.1M | $4.0M | $1.0M | $22.3M | $27.6M | ||
Average Shares Outstanding (Diluted) | $15.1M | $4.0M | $1.0M | $22.3M | $27.6M | ||
Shares Outstanding | $4.3M | $4.3M | $19.0M | $24.7M | $34.6M | ||
Basic EPS | $-2.7 | -- | $-45.05 | $-3.42 | $-3.96 | ||
Basic EPS (Continuing Operations) | $-2.7 | -- | $-45.05 | $-3.42 | $-3.96 | ||
Diluted EPS | $-2.7 | $-17.8 | $-45.05 | $-3.42 | $-3.96 | ||
Diluted EPS (Continuing Operations) | -- | -- | $-45.05 | $-3.42 | $-3.96 | ||
OTHER METRICS | |||||||
Accrued Preferred Stock Dividends | -- | $36.0M | $46.8M | $76.4M | -- | ||
Gain On Sale Of P P E | -- | $300.0K | -- | -- | -- | ||
Other Gand A | $5.9M | $5.8M | $14.0M | $21.9M | $33.0M | ||
Otherunder Preferred Stock Dividend | -- | $36.0M | $46.8M | $76.4M | -- | ||
Preferred Stock Dividends | -- | $36.0M | $46.8M | $76.4M | -- | ||
Rent And Landing Fees | $1.0M | $20.3M | -- | -- | -- | ||
Restruct | -- | $-1.4M | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | IRON | $59.65 | -0.0% | 214.79K |
3 | ||||
4 | ||||
5 | ||||
6 |